Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy

Nat Commun. 2020 Nov 17;11(1):5842. doi: 10.1038/s41467-020-19694-w.

Abstract

Increased lipogenesis has been linked to an increased cancer risk and poor prognosis; however, the underlying mechanisms remain obscure. Here we show that phosphatidic acid phosphatase (PAP) lipin-1, which generates diglyceride precursors necessary for the synthesis of glycerolipids, interacts with and is a direct substrate of the Src proto-oncogenic tyrosine kinase. Obesity-associated microenvironmental factors and other Src-activating growth factors, including the epidermal growth factor, activate Src and promote Src-mediated lipin-1 phosphorylation on Tyr398, Tyr413 and Tyr795 residues. The tyrosine phosphorylation of lipin-1 markedly increases its PAP activity, accelerating the synthesis of glycerophospholipids and triglyceride. Alteration of the three tyrosine residues to phenylalanine (3YF-lipin-1) disables lipin-1 from mediating Src-enhanced glycerolipid synthesis, cell proliferation and xenograft growth. Re-expression of 3YF-lipin-1 in PyVT;Lpin1-/- mice fails to promote progression and metastasis of mammary tumours. Human breast tumours exhibit increased p-Tyr-lipin-1 levels compared to the adjacent tissues. Importantly, statistical analyses show that levels of p-Tyr-lipin-1 correlate with tumour sizes, lymph node metastasis, time to recurrence and survival of the patients. These results illustrate a direct lipogenesis-promoting role of the pro-oncogenic Src, providing a mechanistic link between obesity-associated mitogenic signaling and breast cancer malignancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • CSK Tyrosine-Protein Kinase / genetics*
  • CSK Tyrosine-Protein Kinase / metabolism
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Humans
  • Lipogenesis / physiology
  • Mammary Neoplasms, Animal / genetics
  • Mammary Neoplasms, Animal / pathology
  • Mice, Mutant Strains
  • Mice, Transgenic
  • Phosphatidate Phosphatase / genetics
  • Phosphatidate Phosphatase / metabolism*
  • Phosphorylation
  • Proto-Oncogene Mas
  • Tyrosine / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Tyrosine
  • CSK Tyrosine-Protein Kinase
  • CSK protein, human
  • LPIN1 protein, human
  • Lpin1 protein, mouse
  • Phosphatidate Phosphatase